whisky49: I concur with you that a TO can not be "conjured up". And, incidentally, an opportunistic early TO offer would very likely strongly under-value FAR's assets and hence NOT NECESSARLY be in the best interest of FAR share-holders.
Too many here seem to think that they will "get rich" kind of instantly, whereas I do believe that some more patience is still needed.
However, there is absolutely no doubt in my mind that "in the end" there will be great value coming FAR share-holders way. And my time perspective (perhaps too short but I do not assume so) is that this will be happening within the MONKEY YEAR (or the SENEGALESE ELEPHANTS' YEAR) - the former lapping into 2017, by the way...
Only time will tell. All the best to all FAR holders and an interesting Tuesday ahead. I am already greatly looking forward to the excellent reporting by OOO, which he does with such fantastic dedication and with style! Thanks in advance, OOO !!!
wasa
- Forums
- ASX - By Stock
- FAR
- Cairn Preliminary Results and Cath's MMC Presentation
FAR
far limited
Add to My Watchlist
4.17%
!
34.5¢

Cairn Preliminary Results and Cath's MMC Presentation, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
34.5¢ |
Change
-0.015(4.17%) |
Mkt cap ! $32.80M |
Open | High | Low | Value | Volume |
36.0¢ | 36.0¢ | 34.5¢ | $91K | 255.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 460404 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 0.340 |
1 | 8000 | 0.330 |
1 | 3717 | 0.325 |
1 | 31250 | 0.320 |
1 | 4500 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 55331 | 1 |
0.375 | 33590 | 1 |
0.380 | 11001 | 2 |
0.385 | 4502 | 2 |
0.390 | 31191 | 2 |
Last trade - 11.48am 07/07/2025 (20 minute delay) ? |
Featured News
FAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online